Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
MALVERN, Pa., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at two upcoming investor conferences in November.
| Presentation Details: | |
| Event: | Jefferies London Healthcare Conference |
| Date: | November 18, 2021 |
| Time: | On-demand beginning at 8:00 a.m. GMT (3:00 a.m. ET) |
| Event: | Piper Sandler Annual Healthcare Conference |
| Date: | November 22, 2021 |
| Time: | On-demand beginning at 10 a.m. ET |
Webcasts from the two presentations will be accessible from the Investors page of Galera’s website, investors.galeratx.com. Following the event, archived webcasts will be available on the Galera website for 30 days.
About Galera TherapeuticsGalera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutic candidates that have the potential to transform radiotherapy in cancer. Galera’s technology consists of selective small molecule dismutase mimetics that are in late-stage development in patients with cancer. Avasopasem manganese (GC4419, also referred to as avasopasem) is in development for...
Read Full Story: https://www.streetinsider.com/Globe+Newswire/Galera+to+Present+at+Two+Upcoming+Investor+Conferences+in+November/19212434.html
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.